865 related articles for article (PubMed ID: 26276366)
21. Gastrointestinal stromal tumor - A review of clinical studies.
Khoshnood A
J Oncol Pharm Pract; 2019 Sep; 25(6):1473-1485. PubMed ID: 31068088
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO).
Landi B; Blay JY; Bonvalot S; Brasseur M; Coindre JM; Emile JF; Hautefeuille V; Honore C; Lartigau E; Mantion G; Pracht M; Le Cesne A; Ducreux M; Bouche O; ; ; ; ; ; ;
Dig Liver Dis; 2019 Sep; 51(9):1223-1231. PubMed ID: 31387778
[TBL] [Abstract][Full Text] [Related]
23. A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib.
Jang BH; Kim BW; Lim KJ; Kim BG; Park SM; Kim JS; Ji JS; Choi H
Korean J Gastroenterol; 2015 Jun; 65(6):366-9. PubMed ID: 26087692
[TBL] [Abstract][Full Text] [Related]
24. The GIST of Advances in Treatment of Advanced Gastrointestinal Stromal Tumor.
Schaefer IM; DeMatteo RP; Serrano C
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-15. PubMed ID: 35522913
[TBL] [Abstract][Full Text] [Related]
25. Serum miR-518e-5p is a potential biomarker for secondary imatinib-resistant gastrointestinal stromal tumor.
Kou Y; Yang R; Wang Q
J Biosci; 2018 Dec; 43(5):1015-1023. PubMed ID: 30541960
[TBL] [Abstract][Full Text] [Related]
26. The role of KIT in the management of patients with gastrointestinal stromal tumors.
Hornick JL; Fletcher CD
Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861
[TBL] [Abstract][Full Text] [Related]
27. Review article: the biology, diagnosis and management of gastrointestinal stromal tumours.
Iorio N; Sawaya RA; Friedenberg FK
Aliment Pharmacol Ther; 2014 Jun; 39(12):1376-86. PubMed ID: 24749828
[TBL] [Abstract][Full Text] [Related]
28. The management of metastatic GIST: current standard and investigational therapeutics.
Kelly CM; Gutierrez Sainz L; Chi P
J Hematol Oncol; 2021 Jan; 14(1):2. PubMed ID: 33402214
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal stromal tumors (GIST).
Landi B; Bouche O; Blay JY
Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S98-2S101. PubMed ID: 17151569
[No Abstract] [Full Text] [Related]
30. Practical aspects of risk assessment in gastrointestinal stromal tumors.
Jones RL
J Gastrointest Cancer; 2014 Sep; 45(3):262-7. PubMed ID: 24802226
[TBL] [Abstract][Full Text] [Related]
31. [Similarities and differences in diagnosis and treatment of gastrointestinal stromal tumors between China, Japan and Korea: from expert consensus to cooperation prospect].
Cao H; Wang M
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):812-819. PubMed ID: 31550818
[TBL] [Abstract][Full Text] [Related]
32. Current management of gastrointestinal stromal tumors--a comprehensive review.
Lai EC; Lau SH; Lau WY
Int J Surg; 2012; 10(7):334-40. PubMed ID: 22633986
[TBL] [Abstract][Full Text] [Related]
33. A case of multiple gastrointestinal stromal tumors caused by a germline KIT gene mutation (p.Leu576Pro).
Vale Rodrigues R; Santos F; Pereira da Silva J; Francisco I; Claro I; Albuquerque C; Lemos MM; Limbert M; Dias Pereira A
Fam Cancer; 2017 Apr; 16(2):267-270. PubMed ID: 27771813
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal stromal tumor: advances in diagnosis and management.
Patil DT; Rubin BP
Arch Pathol Lab Med; 2011 Oct; 135(10):1298-310. PubMed ID: 21970485
[TBL] [Abstract][Full Text] [Related]
35. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.
Demetri GD
Semin Oncol; 2001 Oct; 28(5 Suppl 17):19-26. PubMed ID: 11740803
[TBL] [Abstract][Full Text] [Related]
36. KIT over-expression by p55PIK-PI3K leads to Imatinib-resistance in patients with gastrointestinal stromal tumors.
Lai S; Wang G; Cao X; Luo X; Wang G; Xia X; Hu J; Wang J
Oncotarget; 2016 Jan; 7(2):1367-79. PubMed ID: 26587973
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal stromal tumors of the stomach.
Bennett JJ; Rubino MS
Surg Oncol Clin N Am; 2012 Jan; 21(1):21-33. PubMed ID: 22098829
[TBL] [Abstract][Full Text] [Related]
38. NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines.
Demetri GD; Benjamin R; Blanke CD; Choi H; Corless C; DeMatteo RP; Eisenberg BL; Fletcher CD; Maki RG; Rubin BP; Van den Abbeele AD; von Mehren M;
J Natl Compr Canc Netw; 2004 May; 2 Suppl 1():S-1-26; quiz 27-30. PubMed ID: 23573667
[TBL] [Abstract][Full Text] [Related]
39. High-resolution melting analysis is a sensitive diagnostic tool to detect imatinib-resistant and imatinib-sensitive PDGFRA exon 18 mutations in gastrointestinal stromal tumors.
Künstlinger H; Binot E; Merkelbach-Bruse S; Huss S; Wardelmann E; Buettner R; Schildhaus HU
Hum Pathol; 2014 Mar; 45(3):573-82. PubMed ID: 24444465
[TBL] [Abstract][Full Text] [Related]
40. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
Joensuu H; Eriksson M; Sundby Hall K; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Monge OR; Bono P; Kallio R; Vehtari A; Leinonen M; Alvegård T; Reichardt P
JAMA; 2012 Mar; 307(12):1265-72. PubMed ID: 22453568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
